Clinical Trial Update: Edoxaban Compared to Standard Care After Heart Valve Replacement Using a Catheter in Patients With Atrial Fibrillation (ENVISAGE-TAVI AF) [Phase 3]

View source ↗

Summary

Phase 3 trial comparing edoxaban to standard care after transcatheter aortic valve implantation in patients with atrial fibrillation has completed enrollment an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• Edoxaban (edoxaban)

Snippet

Sponsor: Daiichi Sankyo | Conditions: Atrial Fibrillation | Phase 3 | Status: COMPLETED | Results posted: 2022-03-24